PND23 Cost-effectiveness of Fremanezumab from a Societal Perspective in England
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.807
https://www.valueinhealthjournal.com/article/S1098-3015(21)01024-X/fulltext
Title :
PND23 Cost-effectiveness of Fremanezumab from a Societal Perspective in England
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01024-X&doi=10.1016/j.jval.2021.04.807
First page :
Section Title :
Open access? :
No
Section Order :
10312